VAN ECK ASSOCIATES CORP - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 314 filers reported holding BLUEBIRD BIO INC in Q2 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
VAN ECK ASSOCIATES CORP ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q2 2020$5,252,000
+358.3%
86,036
+245.2%
0.01%
+50.0%
Q1 2020$1,146,000
-44.8%
24,926
+5.3%
0.01%
-25.0%
Q4 2019$2,077,000
+6.6%
23,675
+11.5%
0.01%
-11.1%
Q3 2019$1,949,000
-30.5%
21,225
-3.8%
0.01%
-35.7%
Q2 2019$2,806,000
-51.1%
22,058
-39.5%
0.01%
-50.0%
Q1 2019$5,733,000
+15.7%
36,441
-27.1%
0.03%
+12.0%
Q4 2018$4,957,000
-35.7%
49,972
-5.4%
0.02%
-34.2%
Q3 2018$7,710,000
+40.0%
52,809
+50.5%
0.04%
+46.2%
Q2 2018$5,507,000
+2.6%
35,087
+11.6%
0.03%
-3.7%
Q1 2018$5,369,000
-19.8%
31,444
-16.3%
0.03%
-18.2%
Q4 2017$6,694,000
-12.8%
37,587
-32.8%
0.03%
-15.4%
Q3 2017$7,680,000
+62.7%
55,914
+24.5%
0.04%
+50.0%
Q2 2017$4,719,000
-4.3%
44,923
-17.2%
0.03%
+18.2%
Q1 2017$4,929,000
+102.0%
54,227
+37.1%
0.02%
+83.3%
Q4 2016$2,440,000
-16.4%
39,546
-8.2%
0.01%
-14.3%
Q3 2016$2,919,000
+37.0%
43,073
-12.5%
0.01%
+27.3%
Q2 2016$2,130,000
-32.9%
49,209
-34.1%
0.01%
-47.6%
Q1 2016$3,174,000
-37.8%
74,679
-6.0%
0.02%
-47.5%
Q4 2015$5,100,000
-1.9%
79,419
+30.7%
0.04%0.0%
Q3 2015$5,199,00060,7700.04%
Other shareholders
BLUEBIRD BIO INC shareholders Q2 2018
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 6,335,528$40,104,0004.92%
qPULA Trading Management LP 14,344$91,0000.80%
Frazier Life Sciences Management, L.P. 1,440,757$9,120,0000.70%
Ikarian Capital, LLC 462,628$2,928,0000.58%
Birchview Capital, LP 98,000$620,0000.44%
HealthCor Management, L.P. 455,000$2,880,0000.36%
Financial Advocates Investment Management 45,071$3,538,0000.29%
PDT Partners, LLC 262,767$1,663,0000.25%
Monaco Asset Management SAM 80,000$506,0000.19%
Summit X, LLC 103,424$651,0000.19%
View complete list of BLUEBIRD BIO INC shareholders